Table 1 Baseline patient, tumor and treatment characteristics for all patients (n = 50)
Characteristic | All Patients |
|---|---|
Age – mean ± SD | 53.3 ± 12.0 |
Breast Volume (cm3) – mean ± SD | 630 ± 232 |
Tumor location in the breast (quadrants)a – n (%) | |
Superior | 25 (66) |
Inferior | 7 (18) |
Lateral | 23 (61) |
Medial | 6 (16) |
Tumor stage – n (%) | |
T1 | 36 (74) |
T2 | 7 (14) |
T3 | 2 (4) |
Tis | 4 (8) |
Node stage – n (%) | |
N0 | 45 (90) |
NX | 5 (10) |
Nodal investigation – n (%) | |
None | 5 (10) |
Sentinel | 34 (68) |
Axillary | 11 (22) |
Mean Heart Dose (Gy) – mean ± SD | 2.3 ± 0.8 |
Mean Heart Dose (Gy) – n (%) | |
< 1.7 Gy | 10 (20) |
≥ 1.7 Gy | 40 (80) |
Heart Volume (cm3) – mean ± SD | 564 ± 87.2 |
Heart V25 Gy (cm3) – mean ± SD | 10.4 ± 9.7 |
Heart V25 Gy (cm3) – n (%) | |
< 10 cm3 | 27 (54) |
≥ 10 cm3 | 23 (46) |
Maximum LAD Dose (Gy) – mean ± SD | 37.5 ± 15.7 |